Immunostimulatory Activity of Dendritic cells pulsed with carbonic anhydrase IX and Acinetobacter baumannii outer membrane protein A

Journal of Microbiology

Volumn 49, Issue 1, 2011, Pages 115-120

  Kim, Bo Ra ^a   Yang, Eun Kyoung ^a   Kim, Sun Hee ^a   Moon, Dong Chan ^a   Kim, Hwa Jung ^b   Lee, Je Chul ^a   Kim, Duk Yoon ^c  

^a Kyungpook National University School of Medicine   (South Korea)

^b Chungnam National University College of Medicine   (South Korea)

^c Catholic University of Daegu   (South Korea)

Author keywords

carbonic anhydrase IX; dendritic cells; outer membrane protein A; renal cell carcinoma

Indexed keywords

B7 ANTIGEN; CA9 PROTEIN, HUMAN; CANCER VACCINE; CARBONATE DEHYDRATASE; CD86 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERLEUKIN 10; INTERLEUKIN 12; OMPA OUTER MEMBRANE PROTEINS; OUTER MEMBRANE PROTEIN; TUMOR ANTIGEN;

ACINETOBACTER BAUMANNII; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CHEMISTRY; DENDRITIC CELL; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; KIDNEY CARCINOMA; METHODOLOGY; MOUSE; SECRETION; T LYMPHOCYTE;

ACINETOBACTER BAUMANNII; ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, NEOPLASM; BACTERIAL OUTER MEMBRANE PROTEINS; CANCER VACCINES; CARBONIC ANHYDRASES; CARCINOMA, RENAL CELL; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-10; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES;

ACINETOBACTER BAUMANNII; MURINAE;

EID: 79952214885     PISSN: 12258873     EISSN: 12258873     Source Type: Journal    
DOI: 10.1007/s12275-011-1037-x     Document Type: Article

References (28)

1. Bauer, S., J. C. Oosterwijk-Wakka, N. Adrian, E. Oosterwijk, E. Fischer, T. Wüest, F. Stenner, and et al. 2009. Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg. Int. J. Cancer 125, 115-123.
2. Bleumer, I., D. M. Tiemessen, J. C. Oosterwijk-Wakka, M. C. Völler, K. De Weijer, P. F. Mulders, and E. Oosterwijk. 2007. Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells. J. Immunother. 30, 116-122.
3. Bukowski, R. M. 2000. Cytokine combinations: therapeutic use in patients with advanced renal cell carcinoma. Semin. Oncol. 27, 204-212.
4. Chagnon, F., L. Thompson-Snipes, M. Elhilali, and S. Tanguay. 2001. Murine renal cell carcinoma: evaluation of a dendritic-cell tumour vaccine. BJU Int. 88, 418-424.
5. Chagnon, F., S. Tanguay, O. L. Ozdal, M. Guan, Z. Z. Ozen, J. S. Ripeau, M. Chevrette, M. M. Elhilali, and L. A. Thompson-Snipes. 2005. Potentiation of a dendritic cell vaccine for murine renal cell carcinoma by CpG oligonucleotides. Clin. Cancer Res. 11, 1302-1311.
6. Driessens, G., P. Hoffmann, M. Pouwels, A. Zlotta, C. Schulman, T. Velu, and C. A. Bruyns. 2009. Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma. J. Immunother. 32, 140-144.
7. Grabmaier, K., J. L. Vissers, M. C. De Weijert, J. C. Oosterwijk-Wakka, A. van Bokhoven, R. H. Brakenhoff, E. Noessner, and et al. 2000. Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250. Int. J. Cancer 85, 865-870.
8. Hernández, J. M., M. H. Bui, K. R. Han, H. Mukouyama, D. G. Freitas, D. Nguyen, R. Caliliw, and et al. 2003. Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene Clin. Cancer Res. 9, 1906-1916.
9. Hilkens, C. M., P. Kalinski, M. de Boer, and M. L. Kapsenberg. 1997. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 90, 1920-1926.
10. Hillman, G. G., J. P. Droz, and G. P. Haas. 1994. Experimental animal models for the study of therapeutic approaches in renal cell carcinoma. In Vivo 8, 77-80.
11. Inoue, H., M. Iga, H. Nabeta, T. Yokoo, Y. Suehiro, S. Okano, M. Inoue, and et al. 2008. Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines. Cancer Sci. 99, 2315-2326.
12. Jemal, A., R. Siegel, J. Xu, and E. Ward. 2010. Cancer statistics. CA Cancer J. Clin. 60, 277-300.
13. Ko, Y. J. and M. B. Atkins. 2005. Chemotherapies and immunotherapies for metaststic kidney cancer. Curr. Urol. Rep. 6, 35-42.
14. Lee, J. S., J. W. Kim, C. H. Choi, W. K. Lee, H. Y. Chung, and J. C. Lee. 2008. Anti-tumor activity of Acinetobacter baumannii outer membrane protein A on dendritic cell-based immunotherapy against murine melanoma. J. Microbiol. 46, 221-227.
15. Lee, J. S., J. C. Lee, C. M. Lee, I. D. Jung, Y. I. Jeong, E. Y. Seong, H. Y. Chung, and Y. M. Park. 2007. Outer membrane protein A of Acinetobacter baumannii induces differentiation of CD4+ T cells toward a Th1 polarizing phenotype through the activation of dendritic cells. Biochem. Pharmacol. 74, 86-97.
16. Leibovich, B. C., M. L. Blute, J. C. Cheville, C. M. Lohse, I. Frank, E. D. Kwon, A. L. Weaver, A. S. Parker, and H. Zincke. 2003. Prediction of progression after radical nephrectomy for patients with clear cell renal carcinoma: a stratification tool for prospective clinical trials. Cancer 97, 1663-1671.
17. Lim, D. S., J. H. Kim, D. S. Lee, C. H. Yoon, and Y. S. Bae. 2007. DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors. Cancer Immunol. Immunother. 56, 1817-1829.
18. Mukouyama, H., N. K. Janzen, J. M. Hernandez, J. S. Lam, R. Caliliw, A. Y. Wang, R. A. Figlin, A. S. Belldegrun, and G. Zeng. 2004. Generation of kidney cancer-specific antitumor immune responses using peripheral blood monocytes transduced with a recombinant adenovirus encoding carbonic anhydrase 9. Clin. Cancer Res. 10, 1421-1429.
19. Skinner, D. G., R. B. Colvin, C. D. Vermillion, R. C. Pfister, and W. F. Leadbetter. 1971. Diagnosis and management of renal cell carcinoma: a clinical and pathologic study of 309 cases. Cancer 28, 1165-1177.
20. Steinman, R. M. and J. Banchereau. 2007. Taking dendritic cells into medicine. Nature 449, 419-426.
21. Tsan, M. F. and G. Baochong. 2007. Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors. J. Endotoxin Res. 13, 6-14.
22. Uemura, H., Y. Nakagawa, K. Yoshida, S. Saga, K. Yoshikawa, Y. Hirao, and E. Oosterwijk. 1999. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas. Br. J. Cancer. 81, 741-746.
23. Vissers, J. L., I. J. De Vries, L. P. Engelen, N. M. Scharenborg, J. Molkenboer, C. G. Figdor, E. Oosterwijk, and G. J. Adema. 2002. Renal cell carcinoma-associated antigen G250 encodes a naturally processed epitope presented by human leukocyte antigen-DR molecules to CD4+ T lymphocytes. Int. J. Cancer. 100, 441-444.
24. Vissers, J. L., I. J. De Vries, M. W. Schreurs, L. P. Engelen, E. Oosterwijk, C. G. Figdor, and G. J. Adema. 1999. The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2. 1-restricted epitope recognized by cytotoxic T lymphocytes. Cancer Res. 59, 5554-5559.
25. Wang, Y., X. Y. Wang, J. R. Subjeck, and H. L. Kim. 2008. Carbonic anhydrase IX has chaperone-like functions and is an immunoadjuvant. Mol. Cancer Ther. 7, 3867-3877.
26. Wiltrout, R. H., T. A. Gregorio, R. G. Fenton, D. L. Longo, P. Ghosh, W. J. Murphy, and K. L. Komschlies. 1995. Cellular and molecular studies in the treatment of murine renal cancer. Semin. Oncol. 22, 9-16.
27. Winzler, C., P. Rovere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V. S. Zimmermann, J. Davoust, and P. Ricciardi-Castagnoli. 1997. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185, 317-328.
28. Zhou, G. X., J. Ireland, P. Rayman, J. Finke, and M. Zhou. 2010. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials. Urology 75, 257-261.